Strategic Analysis of Downstream Processing in Biopharmaceutical Production


Regular Price: USD 3,950.00

Special Price USD 2,765.00

30% OFF

* Required Fields

Regular Price: USD 3,950.00

Special Price USD 2,765.00


Be the first to review this product

This strategic analysis service provides detailed analysis of world downstream processing markets. The service in powerpoint format (approximately 102 slides) focuses not just only on the revenues and competitor analysis but also on strategies for achieving success in this highly competitive market.

Table of Contents

Strategic Analysis of Downstream Processing in Biopharmaceutical Production, Strategic Analysis of Downstream Processing in Biopharmaceutical ProductionOverviewOverviewResearch Scope & MethodologyResearch Scope & MethodologyIntroduction & BackgroundIntroduction & BackgroundMarket DynamicsMarket DynamicsIndustry ChallengesKey Market TrendsKey Technology TrendsKey Market DriversKey Market RestraintsFuture Technology DynamicsFuture Technology DynamicsKey Technology DriversKey Technology RestraintsBiopharmaceutical Production CostsAnalysis of Emerging TechnologiesIntegrated SolutionsMajor Challenges and Remedial StrategiesContract Manufacturing Organisations (CMOs)Contract Manufacturing Organisations (CMOs)Forecast AssumptionsCMOs in Downstream ProcessingCMO Market DriversCMO Market RestraintsKey Market Engineering MeasurementsTotal Market Revenue ForecastRevenue AnalysisCompetitive ProfilesCMO Geographic DistributionStrategic Analysis & RecommendationsStrategic Analysis & RecommendationsStrategic AnalysisStrategic AnticipationMarket Maturation ProcessCompetitive FrameworkPotential ThreatsMeeting the ChallengeMeeting the Challenge - Product Pricing StrategyMeeting the Challenge - Strategic PosturesFrost & Sullivan AwardsFrost & Sullivan AwardsFrost & Sullivan Awards DescriptionProduct Innovation AwardTechnology Leadership AwardCustomer Service Innovation AwardMarket Leadership AwardProduct Differentiation Innovation AwardDecision Support DatabasesDecision Support DatabasesGlobal Pharmaceutical R&D Expenditure (1999-2006)Number of Biotechnology Companies (1999 - 2006)Top 10 Global Pharmaceutical Drug Sales (2003)Percentage of Pharmaceutical R&D Expenditure (1999-2006)Frost & SullivanHealthcare TeamOur Capabilities

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.